Global Cardiac Assist Devices Market to reach USD XXX billion by 2027Global Cardiac Assist Devices Market is valued approximately USD XXX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2021-2027. Cardiac Assist Devices or CADs are the heart pumping devices that work along-side heart and are used to stabilize the pumping ability and proper maintenance of the blood flow in the body. Increase in the government funding in the research & developmental activities and increasing cases of heart failures and other cardiovascular diseases (CVD's) are the factors contributing to the market growth. For instance, according to World Health Organization (WHO), approximately 17.9 million people died from CVDs in the year 2019 thus representing 32% of the accumulated deaths worldwide. Of these 17.9 million deaths, there were 85% of the deaths that were due to heart failure. However, high costs involved in the treatment of CVD's impedes the growth of the market over the forecast period of 2021-2027. Also, increasing technological innovations are likely to increase the growth of the market in the forecasting period.

The regional analysis of global Cardiac Assist Devices market when considering for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World has led to the analysis that North America is a significant region across the world in terms of market share owing to rising prevalence of CVDs. Whereas, Europe is anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as expansion of health care industries coupled with huge government funding in the research and developmental activities would create lucrative growth prospects for the Cardiac Assist Devices market across Asia-Pacific region.

Major market player included in this report are:

Terumo Corporation
BERLIN HEART GmbH
MAQUET GmbH
Teleflex Incorporated
ABIOMED Inc
Abbott Laboratories
Medtronic PLC
CARMAT SA
Reliant Heart Inc
LIVANOVA PLC



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Ventricular Assist Device
Total Artificial Heart
Intra-Aortic Balloon Pump
Others
By Application:
BTT
Destination Therapy
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Cardiac Assist Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors